|
|
||||||||
The Journal of Immunology, Vol 151, Issue 5 2511-2520, Copyright © 1993 by American Association of Immunologists
ARTICLES |
TW Salcedo, L Azzoni, SF Wolf and B Perussia
Department of Microbiology and Immunology, Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107.
Perforin and granzymes are proteins thought to play a relevant role in cell-mediated cytotoxicity. These molecules are constitutively expressed in NK cells and their level of expression in cytotoxic T lymphocytes is regulated by several cytokines. We analyzed the mechanisms by which cytokines and cellular ligands known to modulate NK cell-mediated cytotoxicity affect the expression of the mRNA encoding granzyme A and B and perforin in NK cells. Our data indicate that IL-2 and IL-12 induce increased accumulation of both perforin and, to a higher degree, granzyme B mRNA. In contrast, binding of target cells or immune complexes up-regulates expression of granzyme B mRNA without altering that of perforin. Results of in situ hybridization experiments confirm that mRNA for both molecules are expressed at low levels in most NK cells, and that both are induced to accumulate by the two cytokines in the majority of the cells. The mechanisms by which IL-2 and IL-12 regulate expression of the two molecules are, in part, distinct: both cytokines increase the transcriptional rate of the encoding genes, whereas only IL-2 acts also at a post-transcriptional level to increase the stability of their mRNA.
This article has been cited by other articles:
![]() |
D. Kumar, J. Hosse, C. von Toerne, E. Noessner, and P. J. Nelson JNK MAPK Pathway Regulates Constitutive Transcription of CCL5 by Human NK Cells through SP1 J. Immunol., January 15, 2009; 182(2): 1011 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Grzywacz, N. Kataria, M. Sikora, R. A. Oostendorp, E. A. Dzierzak, B. R. Blazar, J. S. Miller, and M. R. Verneris Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells Blood, December 1, 2006; 108(12): 3824 - 3833. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huang, E. Bi, Y. Hu, W. Deng, Z. Tian, C. Dong, Y. Hu, and B. Sun A Novel NF-{kappa}B Binding Site Controls Human Granzyme B Gene Transcription J. Immunol., April 1, 2006; 176(7): 4173 - 4181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Pipkin and M. G. Lichtenheld A reliable method to display authentic DNase I hypersensitive sites at long-ranges in single-copy genes from large genomes Nucleic Acids Res., March 1, 2006; 34(4): e34 - e34. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Forte, B. G. Lilienfeld, B. C. Baumann, and J. D. Seebach Human NK Cytotoxicity against Porcine Cells Is Triggered by NKp44 and NKG2D J. Immunol., October 15, 2005; 175(8): 5463 - 5470. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Goldbach-Mansky, S Suson, R Wesley, C E Hack, H S El-Gabalawy, and P P Tak Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis Ann Rheum Dis, May 1, 2005; 64(5): 715 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gismondi, L. Cifaldi, C. Mazza, S. Giliani, S. Parolini, S. Morrone, J. Jacobelli, E. Bandiera, L. Notarangelo, and A. Santoni Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect Blood, July 15, 2004; 104(2): 436 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arjona, N. Boyadjieva, and D. K. Sarkar Circadian Rhythms of Granzyme B, Perforin, IFN-{gamma}, and NK Cell Cytolytic Activity in the Spleen: Effects of Chronic Ethanol J. Immunol., March 1, 2004; 172(5): 2811 - 2817. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Reynaud, N. Lefort, E. Manie, L. Coulombel, and Y. Levy In vitro identification of human pro-B cells that give rise to macrophages, natural killer cells, and T cells Blood, June 1, 2003; 101(11): 4313 - 4321. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Schneider, I. Lorenz, M. Muller-Rosenberger, G. Steinbach, M. Kron, and G. E. Janka-Schaub Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis Blood, September 26, 2002; 100(8): 2891 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, J. Zhang, M. G. Lichtenheld, and G. G. Meadows A Role for NF-{kappa}B Activation in Perforin Expression of NK Cells Upon IL-2 Receptor Signaling J. Immunol., August 1, 2002; 169(3): 1319 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Creus, K. Van Beneden, F. Stevenaert, V. Debacker, J. Plum, and G. Leclercq Developmental and Functional Defects of Thymic and Epidermal V{gamma}3 Cells in IL-15-Deficient and IFN Regulatory Factor-1-Deficient Mice J. Immunol., June 15, 2002; 168(12): 6486 - 6493. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Hodge, A. Martinez, J. G. Julias, L. S. Taylor, and H. A. Young Regulation of Nuclear Gamma Interferon Gene Expression by Interleukin 12 (IL-12) and IL-2 Represents a Novel Form of Posttranscriptional Control Mol. Cell. Biol., March 15, 2002; 22(6): 1742 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mahalingam, G. Karupiah, K. Takeda, S. Akira, K. I. Matthaei, and P. S. Foster Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus PNAS, May 18, 2001; (2001) 111151098. [Abstract] [Full Text] |
||||
![]() |
C.-K. Lee, D. T. Rao, R. Gertner, R. Gimeno, A. B. Frey, and D. E. Levy Distinct Requirements for IFNs and STAT1 in NK Cell Function J. Immunol., October 1, 2000; 165(7): 3571 - 3577. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Lukacher, J. M. Moser, A. Hadley, and J. D. Altman Visualization of Polyoma Virus-Specific CD8+ T Cells In Vivo During Infection and Tumor Rejection J. Immunol., September 15, 1999; 163(6): 3369 - 3378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kozlowski, J. Schorey, T. Portis, V. Grigoriev, and J. Kornbluth NK Lytic-Associated Molecule: A Novel Gene Selectively Expressed in Cells with Cytolytic Function J. Immunol., August 15, 1999; 163(4): 1775 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Galon, C. Sudarshan, S. Ito, D. Finbloom, and J. J. O'Shea IL-12 Induces IFN Regulating Factor-1 (IRF-1) Gene Expression in Human NK and T Cells J. Immunol., June 15, 1999; 162(12): 7256 - 7262. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Grassilli, P. Salomoni, D. Perrotti, C. Franceschi, and B. Calabretta Resistance to Apoptosis in CTLL-2 Cells Overexpressing B-Myb Is Associated with B-Myb-dependent bcl-2 Induction Cancer Res., May 1, 1999; 59(10): 2451 - 2456. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Fogler, K. Volker, M. Watanabe, J. M. Wigginton, P. Roessler, M. J. Brunda, J. R. Ortaldo, and R. H. Wiltrout Recruitment of Hepatic NK Cells by IL-12 Is Dependent on IFN-{gamma} and VCAM-1 and Is Rapidly Down-Regulated by a Mechanism Involving T Cells and Expression of Fas J. Immunol., December 1, 1998; 161(11): 6014 - 6021. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Sayers, A. D. Brooks, J.-K. Lee, R. G. Fenton, K. L. Komschlies, J. M. Wigginton, R. Winkler-Pickett, and R. H. Wiltrout Molecular Mechanisms of Immune-Mediated Lysis of Murine Renal Cancer: Differential Contributions of Perforin-Dependent Versus Fas-Mediated Pathways in Lysis by NK and T Cells J. Immunol., October 15, 1998; 161(8): 3957 - 3965. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Azzoni, O. Zatsepina, B. Abebe, I. M. Bennett, P. Kanakaraj, and B. Perussia Differential Transcriptional Regulation of CD161 and a Novel Gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T Cells J. Immunol., October 1, 1998; 161(7): 3493 - 3500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Allen and M. Nilsen-Hamilton Granzymes D, E, F, and G Are Regulated Through Pregnancy and by IL-2 and IL-15 in Granulated Metrial Gland Cells J. Immunol., September 15, 1998; 161(6): 2772 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Tannenbaum, R. Tubbs, D. Armstrong, J. H. Finke, R. M. Bukowski, and T. A. Hamilton The CXC Chemokines IP-10 and Mig Are Necessary for IL-12-Mediated Regression of the Mouse RENCA Tumor J. Immunol., July 15, 1998; 161(2): 927 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ye, L.-M. Zheng, J. Young, and C.-C. Liu The Involvement of Interleukin (IL)-15 in Regulating the Differentiation of Granulated Metrial Gland Cells in Mouse Pregnant Uterus J. Exp. Med., December 15, 1996; 184(6): 2405 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Robertson and J. Ritz Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment Oncologist, February 1, 1996; 1(1): 88 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. J. Barton, D. K. Blanchard, C. Duan, W. S. Roberts, D. Cavanagh, S. DeCesare, and J. Y. Djeu Interleukin-12 Synergizes With Interleukin-2 to Generate Lymphokine-Activated Killer Activity in Peripheral Blood Mononuclear Cells Cultured in Ovarian Cancer Ascitic Fluid Reproductive Sciences, November 1, 1995; 2(6): 762 - 771. [Abstract] [PDF] |
||||
![]() |
S. Mahalingam, G. Karupiah, K. Takeda, S. Akira, K. I. Matthaei, and P. S. Foster Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus PNAS, June 5, 2001; 98(12): 6812 - 6817. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |